Franz J. Legat
About
Franz J. Legat is a scholar working on Dermatology, Immunology and Allergy and Immunology.
According to data from OpenAlex, Franz J. Legat has authored 71 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Dermatology, 20 papers in Immunology and Allergy and 20 papers in Immunology. Recurrent topics in Franz J. Legat's work include Dermatology and Skin Diseases (44 papers), Psoriasis: Treatment and Pathogenesis (18 papers) and Allergic Rhinitis and Sensitization (17 papers). Franz J. Legat is often cited by papers focused on Dermatology and Skin Diseases (44 papers), Psoriasis: Treatment and Pathogenesis (18 papers) and Allergic Rhinitis and Sensitization (17 papers). Franz J. Legat collaborates with scholars based in Austria, Germany and United States. Franz J. Legat's co-authors include Peter Wolf, Angelika Hofer, Thomas Griesbacher, H. Kerl, Franz Quehenberger, Alexandra Gruber‐Wackernagel, Wolfgang Salmhofer, Sonja Ständer, Gil Yosipovitch and Adam Reich and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.
In The Last Decade
Franz J. Legat
68 papers receiving 1.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Franz J. Legat Austria | 26 | 942 | 372 | 282 | 254 | 242 | 71 | 1.5k | ||
| G. F. Altomare Italy | 24 | 879 0.9× | 902 2.4× | 212 0.8× | 154 0.6× | 293 1.2× | 123 | 1.9k | ||
| Audrey Nosbaum France | 20 | 979 1.0× | 679 1.8× | 122 0.4× | 540 2.1× | 303 1.3× | 111 | 2.0k | ||
| Adrian Tanew Austria | 30 | 1.4k 1.5× | 844 2.3× | 431 1.5× | 279 1.1× | 131 0.5× | 90 | 2.3k | ||
| Yutaka Hatano Japan | 20 | 1.3k 1.3× | 310 0.8× | 107 0.4× | 765 3.0× | 340 1.4× | 90 | 2.0k | ||
| Anà Hennino France | 26 | 882 0.9× | 930 2.5× | 137 0.5× | 466 1.8× | 161 0.7× | 54 | 2.3k | ||
| Michael Jarratt United States | 26 | 1.3k 1.4× | 262 0.7× | 656 2.3× | 162 0.6× | 133 0.5× | 62 | 1.9k | ||
| Serena Lembo Italy | 22 | 653 0.7× | 560 1.5× | 160 0.6× | 75 0.3× | 124 0.5× | 65 | 1.2k | ||
| Manuela Selores Portugal | 15 | 499 0.5× | 332 0.9× | 196 0.7× | 131 0.5× | 187 0.8× | 130 | 1.1k | ||
| Pawinee Rerknimitr Thailand | 17 | 493 0.5× | 176 0.5× | 101 0.4× | 199 0.8× | 280 1.2× | 70 | 1.1k | ||
| Brad A. Yentzer United States | 20 | 961 1.0× | 318 0.9× | 296 1.0× | 117 0.5× | 53 0.2× | 42 | 1.4k |
Countries citing papers authored by Franz J. Legat
Since
Specialization
Citations
This map shows the geographic impact of Franz J. Legat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz J. Legat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz J. Legat more than expected).
Fields of papers citing papers by Franz J. Legat
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Franz J. Legat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz J. Legat. The network helps show where Franz J. Legat may publish in the future.
Co-authorship network of co-authors of Franz J. Legat
This figure shows the co-authorship network connecting the top 25 collaborators of Franz J. Legat. A scholar is included among the top collaborators of Franz J. Legat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franz J. Legat. Franz J. Legat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Stein‐Gold, Linda, Diamant Thaçi, Andrew Pink, et al.. (2024). 733 - Nemolizumab elicits fast itch response in atopic dermatitis within 2 days: a post hoc analysis of ARCADIA 1 and 2 data. British Journal of Dermatology. 191(Supplement_2).
2.
Weißhaar, Elke, Jörg Kupfer, Petra Staubach, et al.. (2024). Validation of the German Pruritus Questionnaire for the systematic assessment of chronic pruritus. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 22(7). 956–963.
3.
Yosipovitch, Gil, Peter Lio, David Rosmarin, et al.. (2024). 497 - Lebrikizumab in combination with topical corticosteroids maintains improvements in itch and sleep at 68 weeks in patients with moderate-to-severe atopic dermatitis. British Journal of Dermatology. 190(Supplement_2). ii6–ii7.
4.
Yosipovitch, Gil, Peter Lio, Franz J. Legat, et al.. (2024). Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks. Dermatology and Therapy. 14(8). 2171–2180.
5.
Ständer, Sonja, Gil Yosipovitch, Franz J. Legat, et al.. (2023). 436 Nemolizumab monotherapy was associated with significant improvements in prurigo activity score in adult patients with moderate-to-severe prurigo nodularis: results from a phase 3 trial (OLYMPIA 2). British Journal of Dermatology. 188(Supplement_3).
6.
Weißhaar, Elke, Jacek C. Szepietowski, Howard Hait, et al.. (2021). Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open‐label extension phase. Journal of the European Academy of Dermatology and Venereology. 36(3). 453–461.
7.
Curiel‐Lewandrowski, Clara, Kathylynn Saboda, Chengcheng Hu, et al.. (2021). In Vivo Reflectance Confocal Microscopy as a Response Monitoring Tool for Actinic Keratoses Undergoing Cryotherapy and Photodynamic Therapy. Cancers. 13(21). 5488–5488.
8.
Fink‐Puches, Regina, Roland Lang, Gudrun Ratzinger, et al.. (2020). Quality of Life, Anxiety, and Depression in Patients With Early-Stage Mycosis Fungoides and the Effect of Oral Psoralen Plus UV-A (PUVA) Photochemotherapy on it. Frontiers in Medicine. 7. 330–330.
9.
Ständer, Sonja, Gil Yosipovitch, Franz J. Legat, et al.. (2020). Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis. New England Journal of Medicine. 382(8). 706–716.
10.
Legat, Franz J.. (2018). Stellenwert der Phototherapie in der Behandlung des chronischen Pruritus. Der Hautarzt. 69(8). 631–640.
11.
Bodenlenz, Manfred, Christoph Magnes, Lukas Schaupp, et al.. (2012). Dermal PK/PD of a lipophilic topical drug in psoriatic patients by continuous intradermal membrane-free sampling. European Journal of Pharmaceutics and Biopharmaceutics. 81(3). 635–641.
12.
Wolf, Peter, Wolfgang Weger, Franz J. Legat, et al.. (2011). Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trial. British Journal of Dermatology. 166(1). 147–153.
13.
Legat, Franz J., et al.. (2007). Psoralen plus UVA vs. UVB‐311 nm for the treatment of lichen planus. Photodermatology Photoimmunology & Photomedicine. 23(1). 15–19.
14.
Hofer, Angelika, et al.. (2005). Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides. British Journal of Dermatology. 154(3). 519–523.
15.
Legat, Franz J. & Peter Wolf. (2005). Photodamage to the cutaneous sensory nerves: role in photoaging and carcinogenesis of the skin?. Photochemical & Photobiological Sciences. 5(2). 170–176.
16.
Horn, M., Peter Wolf, Hans Christian Wulf, et al.. (2003). Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. British Journal of Dermatology. 149(6). 1242–1249.
17.
Legat, Franz J., Thomas Griesbacher, Rudolf Schicho, et al.. (2002). Repeated subinflammatory ultraviolet B irradiation increases substance P and calcitonin gene-related peptide content and augments mustard oil-induced neurogenic inflammation in the skin of rats. Neuroscience Letters. 329(3). 309–313.
18.
Griesbacher, Thomas & Franz J. Legat. (1997). Effects of FR173657, a non‐peptide B2 antagonist, on kinin‐induced hypotension, visceral and peripheral oedema formation and bronchoconstriction. British Journal of Pharmacology. 120(5). 933–939.
19.
Legat, Franz J., et al.. (1996). Evidence for the presence of NK1 and NK3 receptors on cholinergic neurones in the guinea-pig ileum. Neuroscience Letters. 207(2). 125–128.
20.
Legat, Franz J., Thomas Griesbacher, & F. Lembeck. (1992). CP-96,345, a non-peptide antagonist of substance P: I. Effects on the actions mediated by substance P and related tachykinins on the guinea-pig ileum and rabbit jejunum. Naunyn-Schmiedeberg s Archives of Pharmacology. 346(3).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by G. F. Altomare Breakdown of academic impact, for papers by Audrey Nosbaum Breakdown of academic impact, for papers by Adrian Tanew Breakdown of academic impact, for papers by Yutaka Hatano Breakdown of academic impact, for papers by Anà Hennino Breakdown of academic impact, for papers by Michael Jarratt Breakdown of academic impact, for papers by Serena Lembo Breakdown of academic impact, for papers by Manuela Selores Breakdown of academic impact, for papers by Pawinee Rerknimitr Breakdown of academic impact, for papers by Brad A. Yentzer